World Congress Insulin Resistance and Cardiovascular Disease

 

World Congress Insulin Resistance and Cardiovascular Disease

CV Outcome Trials: Impact on Clinical Management of Dyslipidemia in CVD Prevention

By World Congress Insulin Resistance and Cardiovascular Disease
By World Congress Insulin Resistance and Cardiovascular Disease
19 views
March 14, 2018
Comments 0
Login to view comments. Click here to Login
2017 Annual Meeting
16:41

CV Outcome Trials: Impact on Clinical Management of Dyslipidemia in …

World Congress Insulin Resistance and Cardiovascular Disease

19 views
29:13

Lipotoxicity and NAFLD: The Overlooked Complication of T2DM

World Congress Insulin Resistance and Cardiovascular Disease

166 views
09:40

The AACE/ACE Guidelines for the Managment of Dyslipidemia and Preven…

World Congress Insulin Resistance and Cardiovascular Disease

57 views
24:15

Menopause, Estrogens and Lipoprotein Particles

World Congress Insulin Resistance and Cardiovascular Disease

15 views
18:55

Cellular Mechanisms for Lipid Induced Muscle Insulin Resistance

World Congress Insulin Resistance and Cardiovascular Disease

24 views